Boston Scientific‘s fourth quarter of 2014 profits slid down 19 percent. The company reported $87 million in net income, down from $108 million from the prior year period.
David Gill, CFO of EndoChoice, was appointed to the board of directors and chairman of the audit committee of regenerative medicine company Histogenics.
Norton Healthcare, based in Louisville, Ky., has become the first Kentucky healthcare system to offer the non-invasive stool-based colorectal cancer screening test Cologuard from Exact Sciences.
Gilead Sciences plans to allow generic drug makers to produce a new version of its hepatitis C treatment Sovaldi.
Salix Pharmaceuticals promoted William P. Forbes, PharmD, to chief development officer and president of medical, research and development. Prior to his promotion, Dr. Forbes was CDO and executive vice president of medical, research and development.
US Endoscopy released its Roth Net retriever – mini polyp. The Roth Net retriever – mini polyp is designed to offer improved maneuverability and visualization in the colon.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
Is 2015 the year of the GI practice merger?
6 gastroenterologists in the news
GI/endoscopy company stock report – Jan. 30, 2015
